We saw news of financings for stealthy startups in healthcare and IT, as well as an acquisition in the mobile space, and a business competition prize winner.
—Predictive BioSciences raised $25 million in Series C funding, to put towards selling its test for bladder cancer and for developing its diagnostics technology. New investor ProQuest Investments, a Princeton, NJ-based venture firm with offices in San Diego, led the financing round for Lexington, MA-based Predictive. Flybridge Capital Partners, Highland Capital Partners, Kaiser Permanente Ventures, and New Enterprise Associates also put cash towards the Series C.
—Norwood, MA-based Boston Biomedical, a company developing drugs that target stem-cell-like properties of certain cancer cells, wrapped up a $2 million equity offering.
—Affirmed Networks, a Waltham, MA-based telecom startup, grabbed $10.9 million of a planned $11.5 million equity offering. Mass High Tech first reported the funding news and wrote that the company is backed by Matrix Partners and is incubated at Charles River Ventures.
—Cambridge’s Daktari Diagnostics plumped up its Series A round with another $820,000, bringing the financing’s total to $3.7 million. Hub Angels, Launchpad Venture Group, Mass Medical Angels, Norwich Ventures, Partners Innovation Fund, and individual investors have put money toward the round. The Bill & Melinda Gates Foundation, of Seattle, has also put $600,000 into the startup, which is making devices for less expensively monitoring HIV patients in developing countries.
—Jackpot Rewards, a Newton, MA-based provider of online rewards and sweepstakes programs, raised $14.1 million in a convertible debt financing. The company pulled in
